Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Guangzhou Kang Liming Biotechnology

Request full access

The leading advanced bio-tech enterprise in IVD and POCT industry

Guangzhou, ChinaFounded 2015Biotech & Life Sciences

About Guangzhou Kang Liming Biotechnology

Creative Bio is a biotechnology company specializing in early cancer screening and advanced genomic research. The company operates in the healthcare and life sciences market, providing cutting-edge solutions for both clinical and research applications. Creative Bio serves a diverse clientele, including hospitals, research institutions, and academic organizations. The company's business model revolves around the development and commercialization of highly sensitive diagnostic tests and automated laboratory equipment. Revenue is generated through the sale of diagnostic kits, laboratory instruments, and related services. Key products include the Human SDC2 Genomethylation test box and fully automated sample processors, which feature real-time display, data recording, UV light disinfection, and user-friendly touch screen interfaces. Creative Bio's innovative technologies enable accurate and efficient detection of cancer markers, contributing to early diagnosis and improved patient outcomes. The company also engages in scientific research projects, publishes academic journals, and participates in industry events to stay at the forefront of technological advancements.

Source: Dealroom company data

At a glance

Status
Operational
Employees
22
Open positions
4
Dealroom signal
59.4/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES DOther financing Oct 2021 $77M $413M Alibaba · IDG Capital · Cornerstone Capital · Henglu Assets —
SERIES COther financing Sep 2020 $83M $330M IDG Capital · CDH Investments · Qingsong Fund · Oceanpine Capital —
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Guangzhou Kang Liming Biotechnology website traffic

Latest recorded traffic for Guangzhou Kang Liming Biotechnology is 940 monthly website visits, down 55.2% over the last three months. Guangzhou Kang Liming Biotechnology's team grew 0% over the past year.

Latest monthly visits940 3-month web change-55.2% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Guangzhou Kang Liming Biotechnology in the Guangzhou ecosystem

Live from Dealroom

The Guangzhou Kang Liming Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

13 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

Series B and later8 investors entered at this stage

  • Qingsong Fund
  • Oceanpine Capital
  • Jundu investment
  • Alibaba
  • Cornerstone Capital
  • Henglu Assets
  • ABC International
  • Huaxing Fund

Other known investors2 additional known investors

  • Mayo Clinic College of Medicine and Science
  • Sun Yat-sen University
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
7 countries with
team presence
🇨🇳 China38.5%
🇩🇪 Germany15.4%
🇺🇸 United States15.4%
🇨🇱 Chile7.7%
🇲🇾 Malaysia7.7%
Top 5 of 7 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Guangzhou Kang Liming Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Guangzhou Kang Liming Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.